Model Study on Cervical Cancer Screening Strategies and Risk Prediction
NCT ID: NCT06204133
Last Updated: 2024-07-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1112846 participants
OBSERVATIONAL
2023-11-01
2024-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multi-center Application of an AI System for Diagnosis of Cervical Lesions Based on Colposcopy Images
NCT05281939
Artificial Intelligence Enables Precision Diagnosis of Cervical Cytology Grades and Cervical Cancer
NCT04551287
Novel, One Stop, Affordable, Point of Care and AI Supported System of Screening, Triage and Treatment Selection for Cervical Cancer in LMICs
NCT06042543
A Prospective Cohort Study Comparing AI Prediction Model With Imaging Assessment to Diagnose Lymph Node Metastasis in Cervical Cancer
NCT06541288
Automated Cervical Cancer Screening Using a Smartphone-based Artificial Intelligence Classifier
NCT04859530
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Artificial intelligence model building
Using non-image medical data of cervical lesions and clinical pathology results in different medical institutions, machine learning is adopted to establish multiple multi-modal cervical cancer intelligent screening prediction models. This method was used to analyze the prediction performance of the multi-modal cervical cancer intelligent screening prediction and risk triage model, and to evaluate and optimize the self-learning ability of the established multi-modal cervical cancer intelligent screening prediction model.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* There was no history of precancerous lesions or cervical cancer;
* No previous cervical surgery or cervical removal;
Exclusion Criteria
* Pregnant or lactating women;
* There is a serious immune system disease, and the disease is active;
25 Years
64 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fujian Maternity and Child Health Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pengming Sun
Role: STUDY_CHAIR
Fujian Maternal and Child Health Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fujian Maternity and Child Health Hospital
Fuzhou, Fujian, China
Ningde maternal and child health hospital
Ningde, Fujian, China
Gansu Provincial Maternity and Child-care Hospital
Lanzhou, Ganshu, China
Shunde Women's and Children's Hospital of Guangdong Medical University
Foshan, Guangdong, China
Shenzhen Maternal and Child Health Hospital
Shenzhen, Guangdong, China
Guiyang maternal and child health care hospital
Guiyang, Guizhou, China
Hubei Maternal and Child Health Hospital
Wuhan, Hubei, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CSRM2304
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.